Edition:
India

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

11.88USD
18 Oct 2019
Change (% chg)

$-0.18 (-1.49%)
Prev Close
$12.06
Open
$11.96
Day's High
$12.25
Day's Low
$11.55
Volume
97,316
Avg. Vol
53,760
52-wk High
$34.65
52-wk Low
$10.04

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Jul 3.37 -0.420
FY 2019 Apr '19 2.93 -0.496
Jan '19 3.89 -0.230
Oct 5.59 -0.219
Jul 3.72 -0.466
FY 2018 Apr '18 4.84 -0.061
Jan '18 2.33 -0.485
Oct 1.13 -0.498
Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Apr-19 6 4.04 5.03 3.00 --
Quarter Ending Jul-20 1 4.12 4.12 4.12 --
Year Ending Apr-19 6 16.82 17.40 15.30 --
Year Ending Apr-20 7 30.99 73.10 12.40 20.82
Year Ending Apr-21 7 26.92 140.10 0.00 10.00
Earnings (per share)
Quarter Ending Apr-19 5 -0.35 -0.28 -0.44 --
Quarter Ending Jul-20 1 -0.39 -0.39 -0.39 --
Year Ending Apr-19 5 -1.33 -1.18 -1.68 --
Year Ending Apr-20 7 -1.25 1.17 -2.52 -1.99
Year Ending Apr-21 7 -1.95 3.35 -3.79 -4.21
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.88 32.66
P/E High - Last 5 Yrs. -- 42.96 47.30
P/E Low - Last 5 Yrs. -- 23.36 23.87
Beta -- 0.89 0.89
Price to Sales (TTM) 151.44 6.27 7.92
Price to Book (MRQ) 2.63 5.26 5.38
Price to Tangible Book (MRQ) 2.63 5.94 6.72
Price to Cash Flow (TTM) -- 23.50 24.36
% Owned Institutions 80.82 0.76 1.46

Dividends

  Company industry sector
Dividend Yield -- 1.42 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.38
Dividend 5 Year Growth Rate -- 3.90 4.53
Payout Ratio(TTM) -- 42.58 40.23

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,271.43 5.12 12.22
Sales (TTM) vs TTM 1 Yr. Ago 1,503.45 6.49 7.74
Sales - 5 Yr. Growth Rate -- 10.58 10.87
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.02 40.57 42.96
EPS (TTM) vs TTM 1 Yr. Ago 75.80 -- --
EPS - 5 Yr. Growth Rate -- 9.78 10.31
Capital Spending - 5 Yr. Growth Rate -- 15.43 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.20
Current Ratio (MRQ) 7.87 2.93 3.03
LT Debt to Equity (MRQ) 0.80 7.95 10.22
Total Debt to Equity (MRQ) 1.55 11.65 14.57
Interest Coverage (TTM) -29.72 33.53 29.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.83 52.20
Gross Margin - 5 Yr. Avg. -- 49.68 50.41
EBITD Margin (TTM) -4,520.00 -- --
EBITD - 5 Yr. Avg -- 17.36 13.12
Operating Margin (TTM) -4,529.25 13.64 6.77
Operating Margin - 5 Yr. Avg. -- 13.91 8.92
Pre-Tax Margin (TTM) -4,120.21 12.26 5.95
Pre-Tax Margin - 5 Yr. Avg. -- 14.32 9.21
Net Profit Margin (TTM) -4,120.21 9.05 2.59
Net Profit Margin - 5 Yr. Avg. -- 10.75 5.58
Effective Tax Rate (TTM) -- 22.44 22.41
Effective Tax Rate - 5 Yr. Avg. -- 22.49 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 992,493,005 886,862,481
Net Income/Employee (TTM) -- 113,962,481 101,795,790
Receivable Turnover (TTM) -- 5.96 5.96
Inventory Turnover (TTM) -- 2.62 3.36
Asset Turnover (TTM) 0.01 0.97 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.70 11.50 11.12
Return on Assets - 5 Yr. Avg. -- 12.95 12.33
Return on Investment (TTM) -60.80 14.89 14.48
Return on Investment - 5 Yr. Avg. -- 16.85 16.02
Return on Equity (TTM) -61.05 16.01 15.78
Return on Equity - 5 Yr. Avg. -- 17.65 17.01
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -12.01 -15.05 11 24
13 Week 1.40 -3.54 60 40
26 Week -3.33 -10.68 48 41
52 Week -4.10 -18.72 43 10
YTD 2.55 -9.94 47 38
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 88.83%
# of Holders: 117
Total Shares Held: 15,825,648
3 Mo. Net Change: 131,269
# New Positions: 9
# Closed Positions: 2
# Increased Positions: 15
# Reduced Positions: 5
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.